Investor Stock List
Ranked #3,619 of 8,699 institutional investors

Seven Fleet Capital Management LP

Mountain View, CA

$501M
US stock portfolio at live prices · today −$4.7M (−0.93%)
Live prices, last trade 11:35 AM ET
Value at quarter end (Q3 2026)
$512M
Change from Q2 2026
−$94.2M (−15.54%)
Positions
75 · 15 new, 27 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$64.9M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
CGON 30.8%TNGX 9.96%RVMD 8.63%LQDA 6.59%XNCR 2.98%
StockSharesValue, live% of portfoliovs Q2 2026
CGON CG Oncology, Inc.1,886,236$154M30.8%Unchanged
TNGX Tango Therapeutics, Inc.2,232,864$49.9M9.96%Reduced −31%
RVMD Revolution Medicines, Inc.264,588$43.2M8.63%Added +9%
LQDA Liquidia Corporation596,275$33.0M6.59%Added +132%
XNCR Xencor, Inc.444,937$14.9M2.98%Added +21%
ELVN Enliven Therapeutics, Inc.261,957$12.2M2.43%Reduced −28%
MANE Veradermics Inc80,000$9.7M1.94%Unchanged
ASMB Assembly Biosciences, Inc.417,441$9.3M1.85%Reduced −4%
SLN Silence Therapeutics plc350,000$6.9M1.38%Added +482%
ABVX ABIVAX Société Anonyme99,274$6.9M1.38%Reduced −11%
PTGX Protagonist Therapeutics, Inc.45,659$5.6M1.12%Added +1%
IPSC Century Therapeutics, Inc.4,421,739$5.4M1.08%Added +2%
AVTX Avalo Therapeutics, Inc.772,660$5.2M1.04%Added +0%
IMUX Immunic, Inc.687,240$5.0M0.99%New
AVBP ArriVent BioPharma, Inc.451,173$5.0M0.99%Added +83%
DNTH Dianthus Therapeutics, Inc.46,432$3.9M0.78%Reduced −28%
SGMT Sagimet Biosciences Inc.429,113$3.9M0.78%Added +6%
TARS Tarsus Pharmaceuticals, Inc.48,530$3.6M0.72%Reduced −59%
EPRX Eupraxia Pharmaceuticals Inc.572,267$3.4M0.68%Reduced −6%
EDIT Editas Medicine, Inc.1,915,871$3.3M0.66%Added +44%
PRAX Praxis Precision Medicines, Inc.10,489$3.2M0.64%Added +39%
DFTX Definium Therapeutics, Inc.108,647$3.2M0.63%Reduced −27%
AXSM Axsome Therapeutics, Inc.24,066$3.1M0.63%Reduced −17%
RLAY Relay Therapeutics, Inc.185,733$3.0M0.60%Added +4%
TSHA Taysha Gene Therapies, Inc.750,000$2.8M0.56%Reduced −50%
CYTK Cytokinetics, Incorporated53,748$2.8M0.56%Reduced −55%
ZLAB Zai Lab Limited118,395$2.5M0.49%Reduced −13%
CTMX CytomX Therapeutics, Inc.1,085,398$2.2M0.45%Unchanged
ZNTL Zentalis Pharmaceuticals, Inc.1,504,231$2.2M0.44%Added +374%
SABS SAB Biotherapeutics, Inc.752,772$2.1M0.42%Added +2%
NERV Minerva Neurosciences, Inc.1,001,373$2.1M0.41%Unchanged
UTHR United Therapeutics Corporation2,940$1.6M0.33%New
IVA Inventiva S.A.414,341$1.4M0.27%Added +107%
ANTX AN2 Therapeutics, Inc.254,309$1.3M0.26%Added +22%
PCVX Vaxcyte, Inc.22,066$1.3M0.25%Reduced −26%
HRMY Harmony Biosciences Holdings, Inc.37,900$1.3M0.25%New
CLDX Celldex Therapeutics, Inc.40,868$1.1M0.22%Reduced −53%
SYRE Spyre Therapeutics, Inc.11,611$1.1M0.22%Reduced −13%
ANL Adlai Nortye Group Ltd.116,185$1.0M0.20%Added +3%
STRO Sutro Biopharma, Inc.99,894$884K0.18%Reduced −37%
CRVS Corvus Pharmaceuticals, Inc.84,590$821K0.16%Added +2%
SMMT Summit Therapeutics Inc.76,648$785K0.16%Added +5%
CTNM Contineum Therapeutics, Inc.86,654$769K0.15%Added +43%
OKUR OnKure Therapeutics, Inc.240,963$660K0.13%Unchanged
YARW Yarrow Bioscience, Inc.40,000$554K0.11%New
COGT Cogent Biosciences, Inc.19,326$522K0.10%Reduced −87%
IRLA IRulya Therapeutics Inc.11,989$495K<0.1%New
ERAS Erasca, Inc.34,976$491K<0.1%Reduced −89%
AMLX Amylyx Pharmaceuticals, Inc.18,558$480K<0.1%Added +28%
IKT Inhibikase Therapeutics, Inc.358,460$468K<0.1%Added +3%
AVLN Avalyn Pharma Inc.14,710$414K<0.1%New
LONA LeonaBio, Inc.158,253$369K<0.1%Added +3%
MBX MBX Biosciences, Inc.6,810$350K<0.1%Added +14%
CCCC C4 Therapeutics, Inc.140,000$348K<0.1%Reduced −63%
BEAM Beam Therapeutics Inc.15,844$339K<0.1%Added +80%
NGNE Neurogene Inc.14,700$333K<0.1%Reduced −33%
LSTA Lisata Therapeutics, Inc.371,411$330K<0.1%New
IRON Disc Medicine, Inc.4,100$307K<0.1%New
OBX Obsidian Therapeutics, Inc.23,077$277K<0.1%New
PALI Palisade Bio, Inc.272,204$251K<0.1%Unchanged
TECX Tectonic Therapeutic, Inc.12,000$251K<0.1%New
INO Inovio Pharmaceuticals, Inc.137,100$237K<0.1%New
GERN Geron Corporation258,900$235K<0.1%Reduced −76%
CATX Perspective Therapeutics, Inc.296,087$228K<0.1%Reduced −11%
IDYA IDEAYA Biosciences, Inc.7,950$206K<0.1%Reduced −79%
UNCY Unicycive Therapeutics, Inc.51,700$180K<0.1%Reduced −50%
ACRS Aclaris Therapeutics, Inc.44,200$154K<0.1%New
DRUG Bright Minds Biosciences Inc.6,395$136K<0.1%Unchanged
CMPX Compass Therapeutics, Inc.193,034$128K<0.1%Reduced −17%
ABEO Abeona Therapeutics Inc.48,745$120K<0.1%New
FTH Faeth Therapeutics, Inc.10,204$88K<0.1%New
LPCN Lipocine Inc.34,161$50K<0.1%Reduced −57%
IRD Opus Genetics, Inc.10,000$40K<0.1%Reduced −93%
PMN ProMIS Neurosciences, Inc.10,600$32K<0.1%Unchanged
PCSA Processa Pharmaceuticals, Inc.18,300$28K<0.1%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
MIRM Mirum Pharmaceuticals, Inc.110,393$10.8M
MDGL Madrigal Pharmaceuticals, Inc.4,973$1.9M
AGIO Agios Pharmaceuticals, Inc.56,900$1.6M
SVRA Savara Inc.309,103$1.3M
XENE Xenon Pharmaceuticals Inc.33,300$1.2M
RLMD Relmada Therapeutics, Inc.348,265$1000K
CELC Celcuity Inc.16,252$890K
IHI iShares U.S. Medical Devices ETF13,800$774K
ENGN enGene Therapeutics Inc.411,065$721K
SNDX Syndax Pharmaceuticals, Inc.77,930$698K
LRMR Larimar Therapeutics, Inc.230,921$692K
TRVI Trevi Therapeutics, Inc.45,598$607K
KRYS Krystal Biotech, Inc.1,774$559K
EOLS Evolus, Inc.78,057$542K
GPCR Structure Therapeutics Inc.26,800$441K
BCRX BioCryst Pharmaceuticals, Inc.51,024$373K
VYGR Voyager Therapeutics, Inc.230,406$366K
OLMA Olema Oncology, Inc.31,476$224K
STOK Stoke Therapeutics, Inc.7,745$211K
VKTX Viking Therapeutics, Inc.7,404$188K
GLUE Monte Rosa Therapeutics, Inc.16,800$146K
MIST Milestone Pharmaceuticals Inc.270,233$102K
FULC Fulcrum Therapeutics, Inc.18,089$67K
WVE Wave Life Sciences, Inc.19,048$51K
CRBP Corbus Pharmaceuticals Holdings, Inc.21,432$48K
CUE Cue Biopharma, Inc.10,702$45K
PMVP PMV Pharmaceuticals, Inc.53,569$38K